This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Boehringer Ingelheim International Gmbh, Viratherapeutics Gmbh. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 1,564 
1 out of 6 Years Active: 2023-2026
Title: The Innovative Contributions of Philipp Mueller
Introduction
Philipp Mueller is a notable inventor based in Mittelbiberach, Germany. He has made significant contributions to the field of oncolytic viruses, with a focus on developing recombinant rhabdoviruses for cancer treatment. With a total of 4 patents to his name, Mueller's work is paving the way for advancements in cancer therapies.
Latest Patents
Mueller's latest patents include groundbreaking inventions in the realm of oncolytic viruses. One of his patents is for a recombinant rhabdovirus encoding for CCL21. This invention relates to the use of a recombinant rhabdovirus, such as vesicular stomatitis virus, which encodes for a CCL21 protein. The invention aims to utilize this recombinant virus in the treatment of cancer and outlines methods for producing such viruses. Another significant patent is for a recombinant rhabdovirus encoding for a CD80 extracellular domain Fc-fusion protein. Similar to his previous work, this invention focuses on the use of the recombinant virus in cancer treatment and the methods for its production.
Career Highlights
Throughout his career, Philipp Mueller has worked with prominent companies in the biotechnology sector. He has been associated with Boehringer Ingelheim International GmbH and Viratherapeutics GmbH, where he has contributed to innovative research and development projects. His expertise in the field has allowed him to make impactful advancements in cancer therapies.
Collaborations
Mueller has collaborated with notable professionals in his field, including Klaus Erb and Patrik Erlmann. These collaborations have further enhanced his research and development efforts, leading to significant contributions to the scientific community.
Conclusion
Philipp Mueller's innovative work in the field of oncolytic viruses demonstrates his commitment to advancing cancer treatment. His patents and collaborations reflect his dedication to improving therapeutic options for patients. His contributions are a testament to the importance of innovation in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile